Skip to content

Funding
Launch
Partnership
Acquisition
Policy
Exit & IPO

CONNECTA Therapeutics

Spanish Biotech CONNECTA Therapeutics Advances Rare Disease Program with Phase IIa Trial Launch

June 10, 2026 by Marco Bianchi

CONNECTA Therapeutics starts Phase IIa clinical trial with CTH120 for Fragile X Syndrome

Categories Launch Tags CONNECTA Therapeutics, Healthtech, Spain Leave a comment

Browse by Country

Latest

UK Cybersecurity Firm inforcer Raises $50 Million in Series C FundingJul 30, 2026

European VCs Blur Lines Between Investing and Operating as Judith Dada Takes Co-CEO Role at AI Startup LangdockJul 30, 2026

Cologne-Based DeepTech Investor neoteq Closes First Tranche of Second Venture FundJul 30, 2026

Clean Cells Acquires French CRO Anaquant to Expand Protein Characterization ServicesJul 30, 2026

Catawiki Expands Live Auction Platform With Four New Collector CategoriesJul 30, 2026

EU Markets

European Markets Flash Both Green and Red for Startups: What This Week's Financial Moves Mean for YouJul 24, 2026

Defence Funds, AI Warnings, and a €30B Bank Battle: What Europe's Financial Markets Mean for Your Startup This WeekJul 17, 2026

Digital Euros, Defense Billions, and AI Pivots: What Europe's Financial Markets Mean for Your Startup This WeekJul 10, 2026

Techstars Startup Weekend to Put the Isle of Man on the Global Startup MapJul 5, 2026

EU Startups News

• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.